CURRICULUM VITAE. Website: PalmBeachPain.com. Education: University of Pittsburgh Pittsburgh, PA M.D.

Transcription

1 CURRICULUM VITAE Robert J. Friedman, M.D. Board Certified in Neurology Board Certified in Pain Medicine Board Certified in Neuromuscular Medicine Certified Independent Medical Examiner Address: Headache & Pain Center of Palm Beach 1015 W. Indiantown Rd Lake Worth Road Suite 202 Suite 100 Jupiter, FL Lake Worth, FL Telephone: (561) Website: PalmBeachPain.com Education: University of Pittsburgh Pittsburgh, PA M.D Dartmouth College Hanover, NH A.B.; Biology and Psychology; Cum Laude; with distinction in major subject Training: Intern (Internal Medicine) Allegheny General Hospital Pittsburgh, PA Neurology Resident Chief Resident Dartmouth-Hitchcock Medical Center Hanover, NH 5-6/1996 Clinical Fellow Department of Neurology (Pain Management) John Hopkins University Baltimore, MD Interventional Pain Management Training Florida Pain Clinic, Ocala, FL Employment:

2 Friedman, RJ CV Present Robert J. Friedman, M.D. PA / Headache and Pain Center of Palm Beach Jupiter and Lake Worth, FL Palm Beach Neurological Group Palm Beach Gardens and Jupiter, FL Neurological Consultants, Inc. Beverly and Gloucester, MA Tutoring of first-year medical students Research Assistant University of California (San Francisco) Department of Neurology-study of pain 1980 Laboratory Assistant and Phlebotomist New England Deaconess Hospital Boston, MA Positions Held: 2014-Current Member, Professional Practice Committee, American Association of Neuromuscular & Electrodiagnostic Medicine 2012-Current State Liaison for FL, American Association of Neuromuscular & Electrodiagnostic Medicine Co-Chair, FL Society of Neurology-FL Society of PM&R EMG/NCS Taskforce Expert Medical Advisor, FL Division of Workers' Compensation Lake Worth Surgical Center Pain Management Columbia Hospital West Palm Beach-Pain Management Active / Consulting Staff -Jupiter Medical Center FL Attending /Courtesy Staff - Palm Beach Gardens Medical Center FL Consulting Staff- Ocala Regional Hospital, Ocala, FL Consulting Staff -Savannas Hospital, Port St. Lucie, FL Active Staff- Beverly Hospital, Beverly, MA Consulting Staff- Addison Gilbert Hospital, Gloucester, MA Chairman, Subsection of Neurology, Beverly Hospital Chairman, Institutional Review Board, Beverly Hospital Instructor in Clinical Medicine, Dartmouth Medical School Board Certification: 11/1991 Neurology - American Board of Psychiatry and Neurology # /2000 Pain Medicine American Board of Psychiatry and Neurology #13 11/2010 Pain Medicine -ABPN - Recertified 9/2008 Neuromuscular Medicine - American Board of Psychiatry and Neurology #67 2/2007 Certified IME- American Board of Independent Medical Examiners 2/2012 Recertified IME- American Board of Independent Medical Examiners 1986 National Board of Medical Examiners 2/28/1998 American Society of Neuroimaging - MRI/CT Certification

3 Friedman, RJ CV 3 State Medical Licenses: Florida #ME Massachusetts #72897 (previous) Professional Societies: American Academy of Pain Medicine American Association of Neuromuscular & Electrodiagnostic Medicine American Academy of Neurology Florida Academy of Pain Medicine Florida Society of Neurology Florida Medical Association Recent Continuing Medical Education: American Association of Neuromuscular & Electrodiagnostic Medicine 2015 Spring Meeting, Professional Practice Committee Meeting, Chicago, IL May 2, Neuromodec, Brain and Spinal Cord Stimulation in Chronic Pain Syndromes, NYC, January 12, 2015 Neuromodec, NYC Neuromodulation Conference 2015 January 9, January 11, 2015 American Association of Neuromuscular & Electrodiagnostic Medicine 2014 Annual Meeting, Savannah, GA October 29-November 1, American Academy of Pain Medicine 2013 Annual Meeting, Ft. Lauderdale, FL April 11-14th, 2013 American Association of Neuromuscular & Electrodiagnostic Medicine 2012 Annual Meeting, Orlando, FL October 3-6, Florida Academy of Pain Medicine 2012 Annual Meeting, Orlando, FL June 22-24, 2012 American Board of Independent Medical Examiners Meeting, Orlando, FL March 8-11, 2012, including AMA Guides to the Evaluation of Permanent Impairment 6th Edition Training Course. Florida Academy of Pain Medicine 2011 Annual Meeting, Palm Beach, FL August 18-21, 2011 Florida Society of Neurology 2010 Annual Meeting, Lake Buena Vista, FL October 1-3, 2010

4 Friedman, RJ CV 4 Florida Academy of Pain Medicine 2010 Annual Meeting, Palm Beach, FL July 16 18, Intensive Course in Transcranial Magnetic Stimulation, Berenson-Allen Center for Noninvasive Brain Stimulation, Harvard Medical School, Boston, MA, November 9-13, American Association of Neuromuscular & Electrodiagnostic Medicine 2009 Annual Meeting, San Diego-CA, October 7-10, American Academy of Pain Medicine 2008 Annual Meeting, Orlando, FL February 13-15, American Association of Neuromuscular & Electrodiagnostic Medicine 2007 Annual Meeting, Phoenix, AZ, October 7-10, Subspecialty Interests: Headache and Chronic Pain evaluation and treatment Peripheral Nerve Disorders and Neuromuscular Medicine Electromyography and nerve conduction studies Traumatic Neurological Injuries Brain Stimulation Neuroimaging Publication: Alexia without agraphia associated with spleniogeniculate infarction. Neurology 1991 Apr;41(4):587-8 (ISSN: ) Clinical Research Studies (subinvestigator): 1996 Alnitidan-protocol ALN-INT-16, for the Acute Treatment of Migraine. Janssen Phase III. Cerestat-Protocol for the Treatment of Patients with Ischemic Stroke. Boehringer Ingelheim Phase III. Lubeluzole-Protocol LUB-INT-13, for the Treatment of Patients with Ischemic Stroke. Janssen Phase III. Tacrine-Protocol , Treatment of Patients with Dementia of the Alzheimer s type. Parke Davis. Milameline-Protocol for the Treatment of Patients with Probable Alzheimer s Disease. Parke Davis Metrifonate-Protocol X in Patients with Probable Alzheimer s Disease; extension to Protocol D Parke Davis. Metrifonate-Protocol U96-001, Long Term Treatment with Metrifonate for Patients with Probable Alzheimer s Disease. Parke Davis. UCB L059-Protocol RPCE94AI403 Add on Treatment in Epileptic patients with partial onset seizures. UCB S.A., Phanna sector, Phase III. Maximum-Protocol , in the Treatment of acute Migraines, headache pain. Zeneca Pharmaceuticals, Phase III. MK-462 Protocol , in the Treatment of Acute Migraine Pain, extension portion. Merke, Phase III. Rizatriptan-Protocol , in the Treatment of Migraine Pain. Merke. Phase III. UCB-L059-Protocol RPCE-94,T-1403, Follow up study on Treatment in Epileptic Patient with Partial onset seizures,

5 Friedman, RJ CV 5 UCB-SA, Pharma Sector. Phase III L Protocol ,in the Treatment of Postherpetic Neuralgia. Merke, Phase IIA. Rizatriptan/Rapidisc-Protocol ,in the Treatment of Acute Migraine pain. Merke, Phase III. Gabapentin-Protocol , in Treatment of Newly diagnosed With Partial Epilepsy. Parke Davis Phase III. Alniditan S.C.-Protocol ALN-USA-18, in the Treatment of Acute Migraine Attacks. Janssen, Phase III. Alniditan S.C.-Protocol ALN-17, in the Acute Treatment of Migraine. Janssen Phase III. LU25-09-Protocol 9G208, in the Treatment of Alzheimer sdisease. H.Lundbeck A/S, Phase III. Lazabenmide-Protocol PDL-IOOOP, in the Treatment of Alzheimer s Disease. Protodigm,Phase III. Naratriptan-Protocol S2WA4002, for the Treatment of Migraine in subjects who do not respond to Oral Sumatriptan. Glaxo Wellcome, Phase III. Clomethiazole-Protocol SA-CMZ-0009, in the Treatment of Patients with Acute Ischemic Stroke. Astra, Phase II. Clomethiazole-Protocol SA-CMA-0010, in the Treatment of Patients with Acute Intracerebral Hemorrhage. Astra, Phase II. Clomethiazole-Protocol SA-CMZ-0011, in the Treatment of Patients treated with t-pa for acute Ischemic Stroke.Astra Phase II. Metrifonate-Protocol D in the Treatment of Alzheimer s Disease. Bayer, Phase III. Zydis Selegiline-Protocol Z/SEL/97/025, as in Adjunct in the Management of Parkinsonian patients being treated with Levodopa, M.D.S. Harry, Phase III. Sertraline-Protocol R-0552, in elderly patients with major Depression. Pfizer, Phase IV W93-Protocol CIAA2001, in the Acute Treatment of Migraine Headache. Glaxo Wellcome Phase II. Pregabalin-Protocol , for Treatment of painful Diabetic Peripheral Neuropathy. Parke Davis Phase II/III. Idebenone-Protocol PNFP-004, for the Treatment of probable Alzheimer s Disease. Takeda America Phase III. Idebenone-added to Treatment with Donepezil-Protocol PNFP- 007, for Patient with probable Alzheimer s Disease, Takeda America Phase III. Pregabalin-Protocol for the Treatment of Painful Diabetic Neuropathy Parke Davis Phase II/III. Professional References: Available on request Testimony Experience: Available on request